During the past decade, Centro de Investigacion Clinica Chapultepec S. A. de C. V. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Investigacion Clinica Chapultepec S. A. de C. V." #1 sponsor was "Actelion" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Arbor Pharmaceuticals, Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigacion Clinica Chapultepec S. A. de C. V." #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Investigacion Clinica Chapultepec S. A. de C. V." are "Idiopathic Pulmonary Fibrosis" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Erosive Esophagitis" (1 trials). Many other conditions were trialed in "Centro de Investigacion Clinica Chapultepec S. A. de C. V." in a lesser frequency.

Most popular intervention types in "Centro de Investigacion Clinica Chapultepec S. A. de C. V." are "Drug" (11 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexlansoprazole" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Avelumab" (1 trials) and "Azilsartan Medoxomil High-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigacion Clinica Chapultepec S. A. de C. V." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigacion Clinica Chapultepec S. A. de C. V.". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro de Investigacion Clinica Chapultepec S. A. de C. V., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigacion Clinica Chapultepec S. A. de C. V., 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".